Retrospective Evaluation of the Impact of SLCO1B1 Variation on Statin Effectiveness
Journal of Personalized Medicine · 29.10.2025 · 15 (11) · 511
DOI: 10.3390/jpm15110511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 29.10.2025. Verfasst von Mayeesha Ahmed Feldman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, St. Elizabeth Healthcare, Edgewood, KY 41017, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Solute carrier organic anion transporter family member 1B1 (SLCO1B1) mediates statin uptake into hepatocytes, the primary sites of cholesterol production. While the impact of SLCO1B1 variation on statin-associated muscle symptoms (SAMS) is well-documented, its role in LDL-C reduction remains understudied. This single-center, retrospective cohort study evaluated whether SLCO1B1 variation affects statin effectiveness in 213 adults.
Methods
The SLCO1B1 variant rs4149056 (NM_006446.5:c.521T>C) was tested to categorize patients by their SLCO1B1 function: normal, decreased, or poor. The primary endpoint was percent change in LDL-C from baseline to follow-up (≥6 weeks post-statin initiation), with secondary endpoints of SAMS occurrence and statin adherence.
Results
Overall, the average LDL-C decreased by 32% across all groups. No significant difference in LDL-C reduction was observed between SLCO1B1 phenotypes (p = 0.24).
Conclusions
SLCO1B1 variation did not significantly affect LDL-C reduction, SAMS occurrence, or statin adherence. However, the retrospective design and limited adherence data in this study represent important limitations warranting prospective validation studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, St. Elizabeth Healthcare, Edgewood, KY 41017, USA.
- Department of Precision Medicine and Genomic Health, St. Elizabeth Healthcare, Edgewood, KY 41017, USA.
- James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA.
- College of Health Professions, Manchester University, Fort Wayne, IN 46845, USA.
- Ambulatory Care Pharmacy, St. Elizabeth Physicians, Erlanger, KY 41018, USA.
ORCID-Profile: Mayeesha Ahmed Feldman, Kendall Billman, Elizabeth G Schlosser, Josiah D Allen
Zitieren
APA
Ahmed Feldman, M., Billman, K., Sennoun, M., Ng, G., Hussain, M., Schlosser, E. G., Hincapie, A. L., & Allen, J. D. (2025). Retrospective Evaluation of the Impact of SLCO1B1 Variation on Statin Effectiveness. Journal of Personalized Medicine, 15(11), 511. https://doi.org/10.3390/jpm15110511
Vancouver
Ahmed Feldman M, Billman K, Sennoun M, Ng G, Hussain M, Schlosser EG, et al. Retrospective Evaluation of the Impact of SLCO1B1 Variation on Statin Effectiveness. Journal of Personalized Medicine. 2025;15(11):511. doi:10.3390/jpm15110511
BibTeX
@article{AhmedFeldman2025,
author = {Ahmed Feldman, Mayeesha and Billman, Kendall and Sennoun, Mounia and Ng, Gloria and Hussain, Mariam and Schlosser, Elizabeth G and Hincapie, Ana L and Allen, Josiah D},
title = {Retrospective Evaluation of the Impact of SLCO1B1 Variation on Statin Effectiveness},
journal = {Journal of Personalized Medicine},
year = {2025},
volume = {15},
number = {11},
pages = {511},
doi = {10.3390/jpm15110511}
}
EUVIMED